Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Hexcel (HXL)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
$80.62-3.32%
Close 2026-11-05 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.14 → 3.02 EPS · FY ending Dec 31, 2027 · 13 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 11 to 13; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for HXL yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Keep capital spending under $100 million in 2026 | A supporting condition in Hexcel's published investment case. The stated target is <= $100 million. | Broken | Capital spending exceeds $100 million in FY26 | Capital expenditures: $23.7M FY2026-Q3; GAAP. Published target: <= $100 million. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 202623,700,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
HXL is an aerospace growth and operating-improvement story, with robust earnings quality and moderate risk. The long-term thesis has strengthened this week after a reported earnings beat, but recent performance has softened and management execution remains volatile.
HXL is expensive versus peers, trading at a 1.24 premium, while the valuation signal is described as justified and aligned with fundamentals. The expectations gap is negative, suggesting expectations may be demanding; however, the evidence does not show a high level of valuation fragility.
Near term, commercial aerospace sales growth and better operating margins support the business: third-quarter segment sales rose 20.5% year over year, and nine-month adjusted operating margin increased to 12.8%. Nine-month free cash flow also improved, though full-year guidance is not yet confirmed by reported results; a recent quarterly miss and past deep miss remain execution risks despite the latest reported beat.
The multi-year case depends on HXL continuing to support customer production-rate growth while sustaining operating discipline and cash generation. Near term, a reversal of recently raised guidance would damage confidence, while results and guidance from sector bellwethers such as SPCX, GE, and RTX could either support or weaken the industrial-sector backdrop.
For the next 1 to 3 years, HXL has improving operating evidence, but its expensive valuation and uneven execution leave the thesis in watch status. The key test is whether growth and cash generation continue without a guidance reversal. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Hexcel's published investment case. The stated target is EPS between $2.1 and $2.3. |
| Under Pressure |
| EPS falls below $1.7 in FY26 |
Diluted EPS: $0.50 per share FY2026-Q3; GAAP. Published target: EPS between $2.1 and $2.3. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 20260.5 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Generate at least $195 million free cash flow in 2026 | Free cash flow is expected near $195 million. | Under Pressure | Free cash flow falls below $190 million in FY26 | Free cash flow: $50.7M FY2026-Q3; GAAP. Published target: >= $195 million. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 202650,700,000 USD · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve at least $2.0 billion revenue in 2026 | A primary condition in Hexcel's published investment case. The stated target is >= $2.0 billion. | Intact | Revenue falls below $1.88 billion in FY26 | Revenue: $496.4M FY2026-Q3; GAAP. Published target: >= $2.0 billion. Annual target cannot be compared with a quarterly or TTM observation. Oct 21, 2026496,400,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.07 → $3.02 · observed estimates
$2.29B → $2.28B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.07 | $2,290,478,836 | 10 / 11 |
| 2026-07-25 | $3.20 | $2,326,796,740 | 14 / 15 |
| 2026-07-26 | $3.20 | $2,326,796,740 | 14 / 15 |
| 2026-07-27 | $3.20 | $2,326,796,740 | 14 / 15 |
| 2026-07-28 | $3.07 | $2,290,454,129 | 10 / 11 |
| 2026-07-29 | $3.20 | $2,326,796,740 | 14 / 15 |
| 2026-07-30 | $3.20 | $2,326,796,740 | 14 / 15 |
| 2026-07-31 | $3.21 | $2,328,830,070 | 14 / 15 |
| 2026-08-01 | $3.10 | $2,295,882,739 | 10 / 11 |
| 2026-08-02 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-03 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-04 | $3.09 | $2,332,049,790 | 13 / 15 |
| 2026-08-05 | $3.10 | $2,336,719,090 | 14 / 15 |
| 2026-08-06 | $3.10 | $2,336,719,090 | 14 / 15 |
| 2026-08-07 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-08 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-09 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-10 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-12 | $3.12 | $2,338,119,090 | 14 / 15 |
| 2026-08-13 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-14 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-15 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-16 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-17 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-18 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-19 | $3.11 | $2,296,082,160 | 10 / 11 |
| 2026-08-20 | $3.13 | $2,297,316,830 | 10 / 11 |
| 2026-08-21 | $3.13 | $2,297,320,056 | 10 / 11 |
| 2026-08-22 | $3.13 | $2,297,320,056 | 10 / 11 |
| 2026-08-23 | $3.13 | $2,297,320,056 | 10 / 11 |
| 2026-08-24 | $3.13 | $2,297,320,056 | 10 / 11 |
| 2026-08-25 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-08-26 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-08-27 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-08-28 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-08-29 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-08-30 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-08-31 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-01 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-02 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-03 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-04 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-05 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-06 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-07 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-08 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-09 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-10 | $3.13 | $2,297,333,390 | 10 / 11 |
| 2026-09-11 | $3.13 | $2,297,330,164 | 10 / 11 |
| 2026-09-12 | $3.13 | $2,297,330,164 | 10 / 11 |
| 2026-09-13 | $3.13 | $2,297,330,164 | 10 / 11 |
| 2026-09-14 | $3.13 | $2,297,330,164 | 10 / 11 |
| 2026-09-15 | $3.13 | $2,297,330,164 | 10 / 11 |
| 2026-09-16 | $3.13 | $2,297,330,164 | 11 / 11 |
| 2026-09-17 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-18 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-19 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-20 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-21 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-22 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-23 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-24 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-25 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-26 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-27 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-28 | $3.14 | $2,298,083,279 | 11 / 12 |
| 2026-09-29 | $3.15 | $2,302,612,254 | 11 / 12 |
| 2026-09-30 | $3.15 | $2,302,612,254 | 11 / 12 |
| 2026-10-01 | $3.15 | $2,302,612,254 | 11 / 12 |
| 2026-10-02 | $3.15 | $2,302,373,848 | 11 / 12 |
| 2026-10-03 | $3.15 | $2,302,612,254 | 11 / 12 |
| 2026-10-04 | $3.15 | $2,302,612,254 | 11 / 12 |
| 2026-10-05 | $3.15 | $2,302,612,254 | 11 / 12 |
| 2026-10-06 | $3.14 | $2,300,099,754 | 11 / 12 |
| 2026-10-07 | $3.14 | $2,296,949,754 | 11 / 12 |
| 2026-10-08 | $3.14 | $2,296,961,348 | 11 / 12 |
| 2026-10-09 | $3.14 | $2,300,117,598 | 11 / 12 |
| 2026-10-10 | $3.14 | $2,297,742,598 | 11 / 12 |
| 2026-10-11 | $3.14 | $2,297,742,598 | 11 / 12 |
| 2026-10-12 | $3.14 | $2,297,742,598 | 11 / 12 |
| 2026-10-13 | $3.14 | $2,298,169,504 | 11 / 12 |
| 2026-10-14 | $3.14 | $2,298,169,504 | 11 / 12 |
| 2026-10-15 | $3.14 | $2,298,169,504 | 11 / 12 |
| 2026-10-16 | $3.14 | $2,298,281,269 | 12 / 13 |
| 2026-10-17 | $3.14 | $2,298,281,269 | 12 / 13 |
| 2026-10-18 | $3.14 | $2,298,270,357 | 12 / 13 |
| 2026-10-19 | $3.15 | $2,298,270,357 | 12 / 13 |
| 2026-10-20 | $3.15 | $2,298,270,357 | 12 / 13 |
| 2026-10-21 | $3.15 | $2,298,392,553 | 12 / 12 |
| 2026-10-22 | $3.16 | $2,301,358,978 | 12 / 13 |
| 2026-10-23 | $3.14 | $2,298,664,927 | 12 / 13 |
| 2026-10-24 | $3.10 | $2,297,272,626 | 12 / 13 |
| 2026-10-25 | $3.10 | $2,297,272,626 | 12 / 13 |
| 2026-10-26 | $3.10 | $2,297,272,626 | 12 / 13 |
| 2026-10-27 | $3.10 | $2,297,272,626 | 12 / 13 |
| 2026-10-28 | $3.07 | $2,291,024,419 | 12 / 13 |
| 2026-10-29 | $3.03 | $2,288,018,537 | 12 / 13 |
| 2026-10-30 | $3.03 | $2,288,018,537 | 13 / 13 |
| 2026-10-31 | $3.03 | $2,288,018,537 | 13 / 13 |
| 2026-11-01 | $3.03 | $2,287,992,508 | 13 / 13 |
| 2026-11-02 | $3.03 | $2,287,992,508 | 13 / 13 |
| 2026-11-03 | $3.03 | $2,286,863,096 | 13 / 12 |
| 2026-11-04 | $3.02 | $2,284,274,861 | 13 / 12 |
| 2026-11-05 | $3.02 | $2,284,274,861 | 13 / 12 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 10 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 7 recorded
0 raises · 3 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.